263 related articles for article (PubMed ID: 17341654)
1. Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.
Salminen O; Drapeau JA; McIntosh JM; Collins AC; Marks MJ; Grady SR
Mol Pharmacol; 2007 Jun; 71(6):1563-71. PubMed ID: 17341654
[TBL] [Abstract][Full Text] [Related]
2. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.
Salminen O; Murphy KL; McIntosh JM; Drago J; Marks MJ; Collins AC; Grady SR
Mol Pharmacol; 2004 Jun; 65(6):1526-35. PubMed ID: 15155845
[TBL] [Abstract][Full Text] [Related]
3. The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.
Salminen O; Whiteaker P; Grady SR; Collins AC; McIntosh JM; Marks MJ
Neuropharmacology; 2005 Apr; 48(5):696-705. PubMed ID: 15814104
[TBL] [Abstract][Full Text] [Related]
4. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
Gotti C; Moretti M; Clementi F; Riganti L; McIntosh JM; Collins AC; Marks MJ; Whiteaker P
Mol Pharmacol; 2005 Jun; 67(6):2007-15. PubMed ID: 15749993
[TBL] [Abstract][Full Text] [Related]
5. A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.
McClure-Begley TD; Wageman CR; Grady SR; Marks MJ; McIntosh JM; Collins AC; Whiteaker P
J Neurochem; 2012 Jul; 122(1):48-57. PubMed ID: 22506481
[TBL] [Abstract][Full Text] [Related]
6. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
[TBL] [Abstract][Full Text] [Related]
7. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
Azam L; McIntosh JM
Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
[TBL] [Abstract][Full Text] [Related]
8. 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.
Whiteaker P; McIntosh JM; Luo S; Collins AC; Marks MJ
Mol Pharmacol; 2000 May; 57(5):913-25. PubMed ID: 10779374
[TBL] [Abstract][Full Text] [Related]
9. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.
Grady SR; Salminen O; Laverty DC; Whiteaker P; McIntosh JM; Collins AC; Marks MJ
Biochem Pharmacol; 2007 Oct; 74(8):1235-46. PubMed ID: 17825262
[TBL] [Abstract][Full Text] [Related]
10. Functional nicotinic acetylcholine receptors containing α6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons.
Yang K; Buhlman L; Khan GM; Nichols RA; Jin G; McIntosh JM; Whiteaker P; Lukas RJ; Wu J
J Neurosci; 2011 Feb; 31(7):2537-48. PubMed ID: 21325521
[TBL] [Abstract][Full Text] [Related]
11. Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum.
Bordia T; Grady SR; McIntosh JM; Quik M
Mol Pharmacol; 2007 Jul; 72(1):52-61. PubMed ID: 17409284
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.
Sanjakdar SS; Maldoon PP; Marks MJ; Brunzell DH; Maskos U; McIntosh JM; Bowers MS; Damaj MI
Neuropsychopharmacology; 2015 Jan; 40(2):350-60. PubMed ID: 25035086
[TBL] [Abstract][Full Text] [Related]
13. Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain.
Perry DC; Mao D; Gold AB; McIntosh JM; Pezzullo JC; Kellar KJ
J Pharmacol Exp Ther; 2007 Jul; 322(1):306-15. PubMed ID: 17446303
[TBL] [Abstract][Full Text] [Related]
14. Mouse striatal dopamine nerve terminals express alpha4alpha5beta2 and two stoichiometric forms of alpha4beta2*-nicotinic acetylcholine receptors.
Grady SR; Salminen O; McIntosh JM; Marks MJ; Collins AC
J Mol Neurosci; 2010 Jan; 40(1-2):91-5. PubMed ID: 19693710
[TBL] [Abstract][Full Text] [Related]
15. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
[TBL] [Abstract][Full Text] [Related]
16. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.
Marubio LM; Gardier AM; Durier S; David D; Klink R; Arroyo-Jimenez MM; McIntosh JM; Rossi F; Champtiaux N; Zoli M; Changeux JP
Eur J Neurosci; 2003 Apr; 17(7):1329-37. PubMed ID: 12713636
[TBL] [Abstract][Full Text] [Related]
17. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
Kulak JM; McIntosh JM; Quik M
Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
[TBL] [Abstract][Full Text] [Related]
18. Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.
Champtiaux N; Han ZY; Bessis A; Rossi FM; Zoli M; Marubio L; McIntosh JM; Changeux JP
J Neurosci; 2002 Feb; 22(4):1208-17. PubMed ID: 11850448
[TBL] [Abstract][Full Text] [Related]
19. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
Mogg AJ; Whiteaker P; McIntosh JM; Marks M; Collins AC; Wonnacott S
J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717
[TBL] [Abstract][Full Text] [Related]
20. Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function.
Perez XA; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2008 Sep; 74(3):844-53. PubMed ID: 18583454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
